Statistics for Cabaletta Bio (id:8180 CABA)
Valuation metrics
Market cap
184.65M
Enterprise value
58.18K
Trailing P/E (ttm)
-1.13
Forward P/E
-1.57
PEG ratio
-1.57
Price/Sales (ttm)
Price/Book (mrq)
0.91
Enterprise Value/Revenue
Enterprise Value/EBITDA
0.00
Overview
Shares outstanding
48.85M
Float
41.31M
Shares short
3.71M
% Held by insiders
0.03%
% Held by institutions
1.06%
Average volume (10 days)
927.43K
Average volume (90 days)
Price summary
52-Week low
1.76
52-Week high
26.35
52-Week change
-900.00%
Beta
2.42
50-Day moving average
4.27
200-Day moving average
10.77
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-31.13%
Return on equity
-48.16%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-98,614,000.00
Net income to common (ttm)
-89,983,000.00
Diluted EPS (ttm)
-1.91
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
203.22M
Total cash per share (mrq)
4.16
Total debt (mrq)
7.40M
Total Debt/Equity (mrq)
3.71
Current ratio (mrq)
1.15K%
Book value per share (mrq)
4.13
Cash flow
Cash flow statement
-73,829,000.00
Levered free cash flow (LFCF)
-45,623,500.00